Atlas Trials

Qingdao Central Hospital

24 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Qingdao Central Hospital

RecordFirmDate
Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions (NCT07090525)Qingdao Central Hospital2025-07-01
Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer (NCT07090031)Qingdao Central Hospital2025-07-01
Nutrition Impact on Immunotherapy of Cancer (NCT06500234)Qingdao Central Hospital2024-06-01
Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer (NCT06514118)Qingdao Central Hospital2024-04-17
Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer (NCT06138028)Qingdao Central Hospital2023-09-20
Effects of Dapagliflozin on Inflammatory Factorslevel and Prognosis in Type 2 Diabetes With Acute Myocardial Infarction (NCT05050500)Qingdao Central Hospital2023-05-08
Colchicine Use for Primary Prevention of Coronary Artery Disease (NCT05175274)Qingdao Central Hospital2022-12-06
Efficacy and Safety of Rituximab Plus Zanubrutinib and Lenalidomide for Relapsed and Refractory Diffuse Large B Cell Lymphoma, a Multicenter, Open and Prospective Clinical Trial (NCT05392257)Qingdao Central Hospital2022-05-01
Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC (NCT05267366)Qingdao Central Hospital2022-02-01
Anlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic Cancer (NCT05218629)Qingdao Central Hospital2022-01-01
Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction (NCT05060588)Qingdao Central Hospital2021-10-01
Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer (NCT04974879)Qingdao Central Hospital2021-07-01
Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma (NCT04974866)Qingdao Central Hospital2021-07-01
Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer (NCT05267288)Qingdao Central Hospital2021-02-01
Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer (NCT05104281)Qingdao Central Hospital2021-01-01
Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer (NCT03726021)Qingdao Central Hospital2018-01-26

Track Qingdao Central Hospital automatically

Every clearance here is in the API, with alerts when new ones post.